Symbiosis Pharmaceuticals Private Limited's Insider Trades & SAST Disclosures
Symbiosis Pharmaceuticals Private Limited's most recent trade in Prism Medico and Pharmacy Ltd. was a Acquisition of 798,083 Equity Shares done at an average price of Rs. 11 . Disclosure was reported to the exchange on May 26, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Symbiosis Pharmaceuticals Private Limited in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prism Medico & Pharma | Symbiosis Pharmaceuticals Private Limited | Promoter | Acquisition | 26 May 2023 | 798,083 | 848,083 (13.99%) | 13.16% | 11 | 8,778,913 | 22 May 2023 22 May 2023 |
Insider Trading | Equity Shares | Off Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.